image
Healthcare - Biotechnology - NASDAQ - US
$ 3.02
0.667 %
$ 2.53 M
Market Cap
-3.15
P/E
CASH FLOW STATEMENT
-21.3 M OPERATING CASH FLOW
22.92%
-443 K INVESTING CASH FLOW
50.56%
21 M FINANCING CASH FLOW
423.26%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Sonnet BioTherapeutics Holdings, Inc.
image
Net Income -18.8 M
Depreciation & Amortization 75.8 K
Capital Expenditures -443 K
Stock-Based Compensation 249 K
Change in Working Capital -3.12 M
Others -202 K
Free Cash Flow -21.8 M

Cash Flow

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
OPERATING CASH FLOW
Net Income (18.8) (29.7) (25.0) (24.3) (4.9) (6.9) (6.8) (4.3) (14.5)
Depreciation & Amortization 75.8 K 93.3 K 95.2 K 58.3 K 2.2 1.8 2.3 2.3 2.4
Deferred Income Tax 0 0 (0.1) 0 (0.7) (0.8) (0.7) 0.1 94.5 K
Stock Based Compensation 0.2 0.9 1.4 0.4 0.4 0 0 0 0
Other Operating Activities 0.3 1.0 623 6.8 0.5 3.0 6.7 4.7 6.6
Change in Working Capital (3.1) 93.5 K 1.1 1.4 2.1 2.6 1.3 25.2 K 0.3
Cash From Operations (21.3) (27.7) (22.6) (15.6) (2.2) (1.1) (0.7) (0.5) (5.4)
INVESTING CASH FLOW
Capital Expenditures (0.4) (0.9) 3.62 K 76.2 K (2.4) (1.7) (1.6) (1.2) (1.8)
Other Items 0 0 0 0 50 K 0.4 1.2 0.8 (8.7)
Cash From Investing Activities (0.4) (0.9) 3.62 K 76.2 K (2.4) (1.3) (0.4) (0.4) (10.5)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0.1 0 0 68.7 K (0.3) 1.9
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 21.0 2.2 42.8 3.8 (0.5) 0.4 0 0 0.3
Cash From Financing Activities 21.0 4.0 42.8 23.0 2.3 1.3 1.4 22 K 17.1
CHANGE IN CASH
Net Change In Cash (0.8) (24.6) 20.3 7.3 30.2 K 85.6 K 0.2 (1.0) 1.3
FREE CASH FLOW
Free Cash Flow (21.8) (28.6) (22.6) (15.7) (4.6) (2.8) (2.3) (1.7) (7.2)